Dirhodium(II,II) complexes: Molecular characteristics that affect in vitro activity

被引:115
作者
Angeles-Boza, Alfredo M.
Chifotides, Helen T.
Aguirre, J. Dafhne
Chouai, Abdellatif
Fu, Patty K. -L.
Dunbar, Kim R. [1 ]
Turro, Claudia
机构
[1] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA
[2] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA
[3] US FDA, College Pk, MD 20740 USA
关键词
D O I
10.1021/jm060592h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the series Rh-2(O2CR)(4) (R) CH3, 1; R) CF3, 2), [Rh-2(O2CR)(2)(phen)(2)](2+) (R) CH3, 3; R) CF3, 4), and [Rh-2(O2CR)(2)( dppz)(2)](2+) (R) CH3, 5; R) CF3, 6), 2, 4, and 6 are twice as cytotoxic as 1, 3, and 5, respectively. The substitution reactions of 2 with 9-ethylguanine at various temperatures take place at faster rates than those of 1, and the activation energy E-a(1) = 69 +/- 4 kJ/mol is twice E-a(2) = 35 +/- 2 kJ/mol. The higher cytotoxicities of [Rh-2(mu-O2CCH3) 2(eta(1)-O2CCH3) L(MeOH)](+) (L = dppz, 7; L = dppn, 8) relative to [Rh-2(mu-O2CCH3)(2)(bpy) L](2+) (L) dppz, 10; L = dppn, 11) are attributed to the labile equatorial groups in 7 and 8 not present in 10 and 11. The toxicities of complexes 1-8 are not related to their charge or the ease by which they transverse the cellular membrane but to the lability of the ligands on the dirhodium core.
引用
收藏
页码:6841 / 6847
页数:7
相关论文
共 58 条
[51]  
Silverman R. B., 1992, ORGANIC CHEM DRUG DE
[52]   Inhibition of transcription in vitro by anticancer active dirhodium(II) complexes [J].
Sorasaenee, K ;
Fu, PKL ;
Angeles-Boza, AM ;
Dunbar, KR ;
Turro, C .
INORGANIC CHEMISTRY, 2003, 42 (04) :1267-1271
[53]   HYDROPHOBICITY PARAMETERS FOR PLATINUM COMPLEXES [J].
SOUCHARD, JP ;
HA, TTB ;
CROS, S ;
JOHNSON, NP .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (02) :863-864
[54]   Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicity [J].
van Zutphen, S ;
Reedijk, J .
COORDINATION CHEMISTRY REVIEWS, 2005, 249 (24) :2845-2853
[55]   Controlling ligand substitution reactions of organometallic complexes:: Tuning cancer cell cytotoxicity [J].
Wang, FY ;
Habtemariam, A ;
van der Geer, EPL ;
Fernández, R ;
Melchart, M ;
Deeth, RJ ;
Aird, R ;
Guichard, S ;
Fabbiani, FPA ;
Lozano-Casal, P ;
Oswald, IDH ;
Jodrell, DI ;
Parsons, S ;
Sadler, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (51) :18269-18274
[56]   SYNTHESIS, PHOTOPHYSICAL PROPERTIES AND DNA-BINDING STUDIES OF NOVEL LUMINESCENT RHENIUM(I) COMPLEXES - X-RAY CRYSTAL-STRUCTURE OF [RE(DPPN)(CO)(3)(PY)](OTF) [J].
YAM, VWW ;
LO, KKW ;
CHEUNG, KK ;
KONG, RYC .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1995, (11) :1191-1193
[57]   New metal complexes as potential therapeutics [J].
Zhang, CX ;
Lippard, SJ .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2003, 7 (04) :481-489
[58]  
ZYNGIER S, 1989, BRAZ J MED BIOL RES, V22, P397